Psychological Impact of Screening for Risk of Type 1 Diabetes: an Update

No abstract is available for this paper.

• Publication year

  2025

• Venue

  Current Diabetes Reports

• Publication date

  2025-11-13

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1007/s11892-025-01612-3PMID 41231287
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The efficacy of islet autoantibody screening with or without genetic pre-screening strategies for the identification of presymptomatic type 1 diabetes

  2025cited by this paper
• Children's Understanding of Risk for Type 1 Diabetes: The TEDDY Study.

  2025cited by this paper
• Type 1 Diabetes Genetic Risk Scores: History, Application and Future Directions

  2025cited by this paper
• Detection of Islet Autoantibodies in Whole Blood by Antibody Detection by Agglutination-PCR (ADAP) Technology Is Sensitive and Suitable for General Population Screening Programs

  2024cited by this paper
• ISPAD Clinical Practice Consensus Guidelines 2024: Screening, Staging, and Strategies to Preserve Beta-Cell Function in Children and Adolescents with Type 1 Diabetes

  2024cited by this paper
• 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes-2025.

  2024cited by this paper
• Time to reframe the disease staging system for type 1 diabetes.

  2024cited by this paper
• Perceptions and understanding of family pediatricians regarding the new Italian Type 1 Diabetes screening program.

  2024cited by this paper
• Insights into Knowledge and Attitudes About Autoantibody Screening from People Affected by Type 1 Diabetes: A Brief Report

  2024cited by this paper
• Protocol for the Australian Type 1 Diabetes National Screening Pilot: Assessing the feasibility and acceptability of three general population screening models in children

  2024cited by this paper
• Consensus Guidance for Monitoring Individuals With Islet Autoantibody-Positive Pre-Stage 3 Type 1 Diabetes.

  2024cited by this paper
• Consensus guidance for monitoring individuals with islet autoantibody-positive pre-stage 3 type 1 diabetes

  2024cited by this paper
• Attitudes of Parents and Children to Screening for the Risk of Developing Type 1 Diabetes. The ABIS General Population Study

  2024cited by this paper
• Home capillary sampling and screening for type 1 diabetes, celiac disease, and autoimmune thyroid disease in a Swedish general pediatric population: the TRIAD study

  2024cited by this paper
• Developing a General Population Screening Programme for Paediatric Type 1 Diabetes: Evidence from a Qualitative Study of the Perspectives and Attitudes of Parents

  2024cited by this paper
• Implementation of type 1 diabetes genetic risk screening in children in diverse communities: the Virginia PrIMeD project

  2024cited by this paper
• Teplizumab approval for type 1 diabetes in the USA.

  2023cited by this paper
• General population screening for type 1 diabetes using islet autoantibodies at the preschool vaccination visit: a proof-of-concept study (the T1Early study)

  2023cited by this paper
• Teplizumab approval for type 1 diabetes in the USA.

  2023cited by this paper
• Understanding Providers’ Readiness and Attitudes Toward Autoantibody Screening: A Mixed-Methods Study

  2023cited by this paper
• SAI-CH-6: Development of a Short Form of the State Anxiety Inventory for Children At-Risk for Type 1 Diabetes.

  2023influential reference
• Anxiety and Risk Perception in Parents of Children Identified by Population Screening as High Risk for Type 1 Diabetes.

  2023cited by this paper
• Physical Activity and the Development of Islet Autoimmunity and Type 1 Diabetes in 5-15-Year-Old Children Followed in the TEDDY Study.

  2023cited by this paper
• Dietary Intake and Body Mass Index Influence the Risk of Islet Autoimmunity in Genetically At-Risk Children: A Mediation Analysis Using the TEDDY Cohort

  2023cited by this paper
• EarLy Surveillance for Autoimmune diabetes: protocol for a qualitative study of general population and stakeholder perspectives on screening for type 1 diabetes in the UK (ELSA 1)

  2022cited by this paper
• Psychosocial Issues Related to Newborn Screening: A Systematic Review and Synthesis

  2022cited by this paper
• The association of physical activity to oral glucose tolerance test outcomes in multiple autoantibody positive children: The TEDDY Study

  2022cited by this paper
• The emotional well‐being of parents with children at genetic risk for type 1 diabetes before and during participation in the POInT‐study

  2022cited by this paper
• Parental monitoring for type 1 diabetes in genetically at‐risk young children: The TEDDY study

  2021cited by this paper
• Formative Evaluation of the Families SHARE Disease Risk Tool among Low-Income African Americans

  2021cited by this paper
• Yield of a Public Health Screening of Children for Islet Autoantibodies in Bavaria, Germany.

  2020cited by this paper
• An Evaluation of the Safety of Pilots With Insulin-Treated Diabetes in Europe Flying Commercial and Noncommercial Aircraft

  2020cited by this paper
• Adherence to oral glucose tolerance testing in children in stage 1 of type 1 diabetes: The TEDDY study

  2020cited by this paper
• Parent and Pediatrician Preferences for Type 1 Diabetes Screening in the U.S.

  2020cited by this paper
• Predictors of diabetes risk perception among college students

  2019cited by this paper
• Who Is Enrolling? The Path to Monitoring in Type 1 Diabetes TrialNet’s Pathway to Prevention

  2019cited by this paper
• All things considered, my risk for diabetes is medium: A risk personalization process of familial risk for type 2 diabetes

  2019cited by this paper
• Impact of Early Diabetic Ketoacidosis on the Developing Brain

  2018cited by this paper
• Family adjustment to diabetes diagnosis in children: Can participation in a study on type 1 diabetes genetic risk be helpful?

  2018cited by this paper
• Psychosocial effects in parents and children 12 years after newborn genetic screening for type 1 diabetes

  2017cited by this paper
• My Child Is Islet Autoantibody Positive: Impact on Parental Anxiety

  2017influential reference
• Diabetic Ketoacidosis at Diagnosis of Type 1 Diabetes Predicts Poor Long-term Glycemic Control

  2017cited by this paper
• Parental Estimation of Their Child’s Increased Type 1 Diabetes Risk During the First 2 Years of Participation in an International Observational Study

  2016cited by this paper
• Predicting Later Study Withdrawal in Participants Active in a Longitudinal Birth Cohort Study for 1 Year: The TEDDY Study.

  2016cited by this paper
• Participant Experiences in the Environmental Determinants of Diabetes in the Young Study: Common Reasons for Withdrawing

  2015cited by this paper
• Staging Presymptomatic Type 1 Diabetes: A Scientific Statement of JDRF, the Endocrine Society, and the American Diabetes Association

  2015cited by this paper
• Maternal anxiety about a child's diabetes risk in the TEDDY study: the potential role of life stress, postpartum depression, and risk perception

  2015cited by this paper
• Parents’ experiences 12 years after newborn screening for genetic susceptibility to type 1 diabetes and their attitudes to whole-genome sequencing in newborns

  2015cited by this paper
• Neurological Consequences of Diabetic Ketoacidosis at Initial Presentation of Type 1 Diabetes in a Prospective Cohort Study of Children

  2014cited by this paper
• Reduced morbidity at diagnosis and improved glycemic control in children previously enrolled in DiPiS follow‐up

  2014cited by this paper
• Factors Associated With Maternal-Reported Actions to Prevent Type 1 Diabetes in the First Year of the TEDDY Study

  2014cited by this paper
• Differences in recruitment and early retention among ethnic minority participants in a large pediatric cohort: the TEDDY Study.

  2012cited by this paper
• Reasons for Staying as a Participant in the Environmental Determinants of Diabetes in the Young (TEDDY) Longitudinal Study.

  2012cited by this paper
• Psychological Experience of Parents of Children With Type 1 Diabetes

  2012cited by this paper
• Validity of Quality of Life Measurement Tools — From Generic to Disease-specific

  2011cited by this paper
• The Environmental Determinants of Diabetes in the Young (TEDDY) Study: predictors of early study withdrawal among participants with no family history of type 1 diabetes

  2011cited by this paper
• Parents' experiences of newborn screening for genetic susceptibility to type 1 diabetes

  2011cited by this paper
• Psychological Impact of Screening and Prediction in Type 1 Diabetes

  2011cited by this paper
• Reduced Prevalence of Diabetic Ketoacidosis at Diagnosis of Type 1 Diabetes in Young Children Participating in Longitudinal Follow-Up

  2011cited by this paper
• Effects of genetic risk information on children's psychosocial wellbeing: A systematic review of the literature

  2010cited by this paper
• Diabetic Subjects Diagnosed Through the Diabetes Prevention Trial–Type 1 (DPT-1) Are Often Asymptomatic With Normal A1C at Diabetes Onset

  2009cited by this paper
• Participant and parent experiences in the oral insulin study of the Diabetes Prevention Trial for Type 1 Diabetes

  2009cited by this paper
• Practical matters, rather than lack of trust, motivate non‐participation in a long‐term cohort trial

  2009cited by this paper
• Follow-up to

  2006cited by this paper
• Maternal understanding of infant diabetes risk: Differential effects of maternal anxiety and depression

  2006influential reference
• Maternal efforts to prevent type 1 diabetes in at-risk children.

  2005cited by this paper
• Clinical characteristics of children diagnosed with type 1 diabetes through intensive screening and follow-up.

  2004cited by this paper
• Appraisal and implications of predictive testing for insulin-dependent diabetes mellitus.

  1998cited by this paper

• No citing papers are available for this paper.